These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35476975)

  • 41. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.
    Augstein P; Dunger A; Heinke P; Wachlin G; Berg S; Hehmke B; Salzsieder E
    Biochem Biophys Res Commun; 2003 May; 304(2):378-84. PubMed ID: 12711326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
    Chosich N; Harrison LC
    Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IFNγ-Induced MHC Class II Expression on Islet Endothelial Cells Is an Early Marker of Insulitis but Is Not Required for Diabetogenic CD4
    Scott NA; Zhao Y; Krishnamurthy B; Mannering SI; Kay TWH; Thomas HE
    Front Immunol; 2018; 9():2800. PubMed ID: 30555479
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.
    Rivereau AS; You S; Lalain S; Gouin E; Saï P
    Transplantation; 1998 Sep; 66(5):633-8. PubMed ID: 9753345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
    Chen C; Lee WH; Yun P; Snow P; Liu CP
    J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of IL-21 signaling by suppressor of cytokine signaling-1 (SOCS1) in CD8(+) T lymphocytes.
    Gagnon J; Ramanathan S; Leblanc C; Ilangumaran S
    Cell Signal; 2007 Apr; 19(4):806-16. PubMed ID: 17126530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-21 receptor deficiency increases the initial toll-like receptor 2 response but protects against joint pathology by reducing Th1 and Th17 cells during streptococcal cell wall arthritis.
    Marijnissen RJ; Roeleveld DM; Young D; Nickerson-Nutter C; Abdollahi-Roodsaz S; Garcia de Aquino S; van de Loo FA; van Spriel AB; Boots AM; van den Berg WB; Koenders MI
    Arthritis Rheumatol; 2014 Apr; 66(4):886-95. PubMed ID: 24757141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice.
    Shimizu J; Kanagawa O; Unanue ER
    J Immunol; 1993 Aug; 151(3):1723-30. PubMed ID: 8101546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interferon-γ Limits Diabetogenic CD8
    Driver JP; Racine JJ; Ye C; Lamont DJ; Newby BN; Leeth CM; Chapman HD; Brusko TM; Chen YG; Mathews CE; Serreze DV
    Diabetes; 2017 Mar; 66(3):710-721. PubMed ID: 27920091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B-cell cross-presentation of autologous antigen precipitates diabetes.
    Mariño E; Tan B; Binge L; Mackay CR; Grey ST
    Diabetes; 2012 Nov; 61(11):2893-905. PubMed ID: 22829452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppressors of cytokine signaling inhibit effector T cell responses during Mycobacterium tuberculosis infection.
    Srivastava V; Vashishta M; Gupta S; Singla R; Singla N; Behera D; Natarajan K
    Immunol Cell Biol; 2011 Oct; 89(7):786-91. PubMed ID: 21537342
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells.
    Yu CR; Kim SH; Mahdi RM; Egwuagu CE
    J Immunol; 2013 Nov; 191(10):5036-43. PubMed ID: 24101549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paralytic autoimmune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN-gamma receptor beta-chain transgene.
    Serreze DV; Pierce MA; Post CM; Chapman HD; Savage H; Bronson RT; Rothman PB; Cox GA
    J Immunol; 2003 Mar; 170(5):2742-9. PubMed ID: 12594305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppressor of cytokine signalling 1 (SOCS1) is a physiological regulator of the asthma response.
    Lee C; Kolesnik TB; Caminschi I; Chakravorty A; Carter W; Alexander WS; Jones J; Anderson GP; Nicholson SE
    Clin Exp Allergy; 2009 Jun; 39(6):897-907. PubMed ID: 19309352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Level of major histocompatibility complex class I expression on endothelium in non-obese diabetic mice influences CD8 T cell adhesion and migration.
    Lozanoska-Ochser B; Peakman M
    Clin Exp Immunol; 2009 Jul; 157(1):119-27. PubMed ID: 19659777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Perforin facilitates beta cell killing and regulates autoreactive CD8+ T-cell responses to antigen in mouse models of type 1 diabetes.
    Trivedi P; Graham KL; Krishnamurthy B; Fynch S; Slattery RM; Kay TW; Thomas HE
    Immunol Cell Biol; 2016 Apr; 94(4):334-41. PubMed ID: 26446877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucagon-reactive islet-infiltrating CD8 T cells in NOD mice.
    Mukherjee G; Chaparro RJ; Schloss J; Smith C; Bando CD; DiLorenzo TP
    Immunology; 2015 Apr; 144(4):631-40. PubMed ID: 25333865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
    Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
    Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased entry into the IFN-gamma effector pathway by CD4+ T cells selected by I-Ag7 on a nonobese diabetic versus C57BL/6 genetic background.
    Koarada S; Wu Y; Ridgway WM
    J Immunol; 2001 Aug; 167(3):1693-702. PubMed ID: 11466393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of interferon-induced Stat1 phosphorylation in activated T cells.
    Van De Wiele CJ; Marino JH; Whetsell ME; Vo SS; Masengale RM; Teague TK
    J Interferon Cytokine Res; 2004 Mar; 24(3):169-78. PubMed ID: 15035850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.